IP Library Granted Patent US 12,551,280
Granted Patent B2
US 12,551,280 · App. 16/746,231 · Granted Feb 17, 2026

Systems and methods for intraocular lens selection using emmetropia zone prediction

Inventors: Ramesh Sarangapani (Coppell, TX); Mark VonTress (Arlington, TX)
Assignee: Alcon Inc.
A61B34/10A61B3/117A61F2/16G16H50/20G16H50/50A61B2034/108G06N20/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,280
App. No.
16/746,231
Granted
Feb 17, 2026
Kind
B2
Abstract

Systems and methods for intraocular lens (IOL) selection using emmetropia zone prediction include determining pre-operative measurements of an eye, estimating a post-operative anterior chamber depth (ACD) of an intraocular lens based on the pre-operative measurements, estimating a post-operative manifest refraction in spherical equivalent (MRSE) of the eye with the IOL implanted based on the pre-operative measurements and the estimated post-operative ACD, determining whether the eye with the IOL implanted is likely to be in an emmetropia zone based on the estimated post-operative MRSE, re-estimating the post-operative MRSE of the eye with the IOL implanted using an emmetropia zone prediction model or a non-emmetropia zone prediction model based on the emmetropia zone determining, and providing the re-estimated post-operative MRSE to a user to aid in selection of an IOL for implantation in the eye.

Claims (23)

1 . A system comprising: one or more optical biometers configured to obtain one or more pre-operative measurements of an eye of a current patient;

a prediction engine comprising:

one or more processors; and memory containing a plurality of machine-readable instructions which when executed by one or more processors are adapted to cause the one or more processors to:

train a neural network emmetropia zone prediction model using a set of data from a collection of eyes of a plurality of previous patients, wherein the set of data includes an estimated post-operative manifest refraction in spherical equivalent (MRSE) for each of the plurality of previous patients and an actual post-operative MRSE for each of the plurality of previous patients where a post-operative eye was placed in an emmetropia zone of the previous patients;

train a neural network non-emmetropia zone prediction model using a set of data from a collection of eyes of previous patients, wherein the set of data includes an estimated post-operative manifest refraction in spherical equivalent (MRSE) for each of the plurality of previous patients and an actual post-operative MRSE for each of the plurality of previous patients where a post-operative eye was placed in a non-emmetropia zone of the previous patients;

receive, from the one or more optical biometer, the one or more pre-operative measurements of the eye of the current patient;

estimate, based on the one or more pre-operative measurements of the eye of the current patient, a post-operative anterior chamber depth (ACD) of an intraocular lens (IOL);

estimate, based on the one or more pre-operative measurements of the eye of the current patient and the estimated post-operative ACD, a post-operative manifest refraction in spherical equivalent (MRSE) of the eye of the current patient with the IOL implanted;

determine, based on the estimated post-operative MRSE, whether the eye of the current patient with the IOL implanted is likely to be in an emmetropia zone;

selecting the emmetropia zone prediction model based on determining that the eye of the current patient with the IOL implanted has a likelihood greater than or equal to a threshold value as being in the emmetropia zone, re-estimate the post-operative MRSE of the eye with the IOL implanted using the emmetropia zone prediction model, and

selecting the non-emmetropia zone prediction model based on determining that the eye of the current patient with the IOL implanted is not likely to be in the emmetropia zone, re-estimate the post-operative MRSE of the eye with the IOL implanted using the non-emmetropia zone prediction model; and

provide the re-estimated post-operative MRSE to a user to aid in selection of an IOL for implantation in the eye of the current patient;

wherein the one or more optical biometers are further configured to:

obtain one or more postoperative measurements of the eye of the current patient with the IOL implanted; and

update, based on the one or more post-operative measurements of the eye of the current patient, one of the neural network non-emmetropia zone prediction model or the neural network emmetropia zone prediction model.

2 . The system of claim 1 , wherein to estimate the post-operative ACD, the prediction engine is configured to:

generate a first estimate using a geometric model of the eye; and

update the first estimate using a neural network-based prediction model.

3 . The system of claim 1 , wherein to determine whether the eye with the IOL implanted is in the emmetropia zone, the prediction engine is configured to use a classifier and a receiver operator characteristic curve.

4 . The system of claim 1 , wherein the prediction engine is further configured to:

estimate and re-estimate a post-operative MRSE of a second IOL; and

present the re-estimated post-operative MRSE of the IOL and the re-estimated post-operative MRSE of the second IOL to the user to aid the user in the selection of the IOL for implantation in the eye;

wherein the IOL and the second IOL have different IOL powers.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2020
From: SARANGAPANI, RAMESH; VONTRESS, MARK
To: ALCON RESEARCH, LTD.
Reel/Frame 051808/0535 →
CHANGE OF NAME Recorded Feb 13, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 051808/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 051809/0441 →
Continuity (2)
Provisional Application 62795297 · Jan 22, 2019
Related Publication 20200229870A1 · Jul 23, 2020
References Cited (38)
US 20030053025A1 · Turner · 2003 [cited by applicant]
US 20030214628A1 · Patel · 2003 [cited by applicant]
US 20040246440A1 · Andino · 2004 [cited by examiner]
US 20110242482A1 · Olsen · 2011 [cited by applicant]
US 20140028973A1 · Scolaro · 2014 [cited by applicant]
US 20150103313A1 · Sarver · 2015 [cited by applicant]
US 20170105617A1 · Li · 2017 [cited by applicant]
US 20170273779A1 · Zhao · 2017 [cited by examiner]
US 20170316571A1 · Martínez-enríquez · 2017 [cited by applicant]
US 20180235809A1 · Dai · 2018 [cited by applicant]
US 20180296320A1 · Gupta · 2018 [cited by examiner]
US 20180368970A1 · Findl · 2018 [cited by applicant]
AU 2011292287B2 · 2015 [cited by examiner]
CA 2736784A1 · 2010 [cited by applicant]
CN 1642500A · 2005 [cited by applicant]
CN 103565395A · 2014 [cited by applicant]
CN 107072528A · 2017 [cited by applicant]
CN 107077524A · 2017 [cited by applicant]
EP 2653095A1 · 2013 [cited by applicant]
JP 2013236902A · 2013 [cited by applicant]
JP 2016533781A · 2016 [cited by applicant]
JP 2017505698A · 2017 [cited by applicant]
JP 2017077250A · 2017 [cited by applicant]
JP 2018015440A · 2018 [cited by applicant]
WO 0185066A1 · 2001 [cited by applicant]
WO 03082162A2 · 2003 [cited by applicant]
WO 2010028654A1 · 2010 [cited by applicant]
WO WO2013059663A2 · 2013 [cited by examiner]
WO 2015117155A1 · 2015 [cited by applicant]
WO 2016008584A2 · 2016 [cited by applicant]
WO 2016029032A1 · 2016 [cited by applicant]
WO 2017180914A1 · 2017 [cited by applicant]
WO WO2018021561A1 · 2018 [cited by examiner]
Canovas et al., Customized eye models for determining optimized intraocular lenses power, Jun. 2011, Biomedical Optics Express, pp. 1649-1663 (Year: 2011). [cited by examiner]
Barden, What is emmetropia?, Apr. 2021, All About Vision, pp. 1-3 (Year: 2021). [cited by examiner]
Translation for WO-2018021561; Endo et al., Ophthalmologic Device and IOL Power Determination Program, 2018, Japan, pp. 1-27 (Year: 2018). [cited by examiner]
Translation/Pub for WO-2013059663; Morris et al., Patient Screening Factors for Accommodative Implantable Ophthalmic Devices, 2013, WIPO, pp. 1-44 (Year: 2013). [cited by examiner]
Canovas Vidal et al., Customized intraocular lens power calculation system and method, 2012, Australian Patent Office, pp. 1-48 ( Year: 2012). [cited by examiner]